The epidemiology of acne vulgaris in late adolescence

DD Lynn, T Umari, CA Dunnick… - … health, medicine and …, 2016 - Taylor & Francis
Importance Acne vulgaris is the most common skin condition affecting late adolescents
across the globe. Although prior studies have evaluated epidemiologic patterns of acne …

Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk

L Morimont, H Haguet, JM Dogné, U Gaspard… - Frontiers in …, 2021 - frontiersin.org
Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease

M Alexander, AK Loomis, J Fairburn-Beech… - BMC medicine, 2018 - Springer
Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver
disease worldwide. It affects an estimated 20% of the general population, based on cohort …

[HTML][HTML] A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception

MV Dragoman, NK Tepper, R Fu… - … of Gynaecology and …, 2018 - ncbi.nlm.nih.gov
Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

Combined oral contraceptives: venous thrombosis

M de Bastos, BH Stegeman… - Cochrane Database …, 2014 - cochranelibrary.com
Background Combined oral contraceptive (COC) use has been associated with venous
thrombosis (VT)(ie, deep venous thrombosis and pulmonary embolism). The VT risk has …

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Ø Lidegaard, LH Nielsen, CW Skovlund… - Bmj, 2011 - bmj.com
Objective To assess the risk of venous thromboembolism from use of combined oral
contraceptives according to progestogen type and oestrogen dose. Design National …

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Ø Lidegaard, E Løkkegaard, AL Svendsen, C Agger - Bmj, 2009 - bmj.com
Objective To assess the risk of venous thrombosis in current users of different types of
hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and …

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

A van Hylckama Vlieg, FM Helmerhorst… - Bmj, 2009 - bmj.com
Objective To assess the thrombotic risk associated with oral contraceptive use with a focus
on dose of oestrogen and type of progestogen of oral contraceptives available in the …

[PDF][PDF] Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases

Y Vinogradova, C Coupland, J Hippisley-Cox - bmj, 2015 - bmj.com
Objective To investigate the association between use of combined oral contraceptives and
risk of venous thromboembolism, taking the type of progestogen into account. Design Two …

Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study

A Weill, M Dalichampt, F Raguideau, P Ricordeau… - bmj, 2016 - bmj.com
Objective To assess the risk of pulmonary embolism, ischaemic stroke, and myocardial
infarction associated with combined oral contraceptives according to dose of oestrogen …